APOE rs405509 polymorphism and Parkinson's disease risk in the Chinese population.

Neuroscience Letters
Ming HuangYu Hu

Abstract

Parkinson's disease (PD) is the second most common progressive neurodegenerative disorder with complex etiology involving both genetic and environmental factors. Apolipoprotein E (ApoE) rs405509 (-219 T/G), a promoter SNP, controls the expression of APOE gene, and plays a modifier effect of APOE ε4 on the susceptibility of Alzheimer's disease. In this study, we investigate the association between APOE rs405509 polymorphism and the susceptibility of PD in a Chinese population. A total of 1020 subjects were collected including 510 sporadic PD patients (mean age: 63.11 ± 9.28 years) and 510 healthy control subjects (mean age: 62.97 ± 9.09 years). APOE rs405509 polymorphism was genotyped using a TaqMan genotyping method. The Hardy-Weinberg Equilibrium (HWE) was calculated for the control group by Chi-square (χ2) test. The strength of this association between the APOE rs405509 polymorphism and PD risk was evaluated with crude odds ratios (ORs) and 95 % confidence intervals (CIs) using a logistic regression analysis. The T allele frequency was 0.84 and 0.70 in the PD and control groups, respectively. T allele carriers of rs405509 were associated with an increased overall risk of PD and in male subjects in the allele, recessive, and a...Continue Reading

References

May 29, 2000·The New England Journal of Medicine·C B LückingUNKNOWN European Consortium on Genetic Susceptibility in Parkinson's Disease
Feb 27, 2007·Neuroscience Letters·David A ElliottBrett Garner
Jun 2, 2015·The International Journal of Biochemistry & Cell Biology·Hannah LokeJoohyung Lee
Oct 17, 2015·Movement Disorders : Official Journal of the Movement Disorder Society·Ronald B PostumaGünther Deuschl
Jun 21, 2016·Parkinsonism & Related Disorders·David MengelRichard Dodel
Nov 8, 2016·Molecular and Cellular Probes·Christina M Lill
Feb 13, 2017·La Presse médicale·Anna Delamarre, Wassilios G Meissner
Aug 21, 2019·Journal of Clinical Medicine·Kyu Yeong ChoiAlzheimer's Disease Neuroimaging Initative
Sep 11, 2019·Movement Disorders : Official Journal of the Movement Disorder Society·Hirotaka IwakiMike A Nalls

❮ Previous
Next ❯

Citations

Feb 21, 2021·Molecular Neurobiology·Efthalia AngelopoulouChristina Piperi

❮ Previous
Next ❯

Related Concepts

Related Feeds

Alzheimer's Disease: APOE

Apolipoprotein E (APOE) polymorphic alleles are major genetic risk factors for Alzheimer's disease. Discover the latest research on APOE and other genetic determinants of Alzheimer's disease here.

ApoE Phenotypes

Apolipoprotein E (APOE) is a protein involved in fat metabolism and associated with the pathogenesis of Alzheimer's disease and cardiovascular disease. Here is the latest research on APOE phenotypes.